Experimental drug shows promise against head and neck cancer

A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck. The work is reported in the April 28th online edition of the Journal of Pathology.

If you want to include this story in your blog, copy and paste this formatted text: